Abstract

CorrigendumCorrigendum for Aishah et al., vol. 130, 2021, p. 1373–1382Published Online:25 Dec 2022https://doi.org/10.1152/japplphysiol.01074.2020_COROriginal articleMoreSectionsPDF (107 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInWeChat Aishah A, Lim R, Sands SA, Taranto-Montemurro L, Wellman A, Carberry JC, Eckert DJ. Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity. J Appl Physiol (1985) 130: 1373–1382, 2021. First published March 18, 2021. doi: 10.1152/japplphysiol.01074.2020.The placebo and P values for diastolic data points in Table 4 were incorrect as originally published. The comparison remains nonsignificant, and the authors assert that the correction does not affect the results of the study. The corrected Table 4 appears below.Table 4. Effect of the drug combinations on next-morning driving simulator performance, blood pressure, and neck circumference compared with placeboAto-SolPAto-BipPPlaceboSteering deviation from median of lane, cm56.9 ± 29.30.2457.4 ± 31.10.2449.6 ± 25.0Speeding deviation from 60 to 80 km/h, km/h4.3 ± 6.40.503.9 ± 6.40.504.6 ± 7.6Individuals that crashed, %201.00201.0020Breaking reaction time, ms950 ± 1000.78920 ± 1000.781,000 ± 300Systolic, mmHg136 ± 19.20.77133 ± 18.80.77133 ± 14.5Diastolic, mmHg89.8 ± 15.20.2885.5 ± 13.80.2887.9 ± 12.0Neck circumference, cm40.9 ± 3.50.0640.8 ± 4.10.0642.4 ± 3.1Data are means ± SD. Pairwise comparisons were performed using the Student–Newman–Keuls method or Wilcoxon signed-rank test. *P < 0.05 (driving stimulator task n = 6, neck circumference n = 7). Ato-Bip, atomoxetine plus biperiden hydrochloride; Ato-Sol, atomoxetine plus solifenacin succinate. Boldface indicates data that have been corrected from the original version.This article has no references to display. Download PDF Previous Back to Top FiguresReferencesRelatedInformation Collections Related ArticlesDifferent antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity 02 May 2021Journal of Applied Physiology More from this issue > Volume 134Issue 1January 2023Pages 84-84 Crossmark Copyright & PermissionsCopyright © 2023 the American Physiological Society.https://doi.org/10.1152/japplphysiol.01074.2020_CORPubMed36566446History Published online 25 December 2022 Published in print 1 January 2023 Metrics

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call